<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="produced two epidemics SARS CoV (2002-03), MERS CoV (2014-16).[2] An" exact="acute" post="respiratory illness broke out in Wuhan, China in December"/>
 <result pre="two epidemics SARS CoV (2002-03), MERS CoV (2014-16).[2] An acute" exact="respiratory" post="illness broke out in Wuhan, China in December 2019."/>
 <result pre="belonging to the genera betacoronavirus found to be causing this" exact="disease" post="Corona Virus Disease-2019 (COVID- 19)) is presently classified as"/>
 <result pre="Corona Virus Disease-2019 (COVID- 19)) is presently classified as severe" exact="acute" post="respiratory syndrome CoV 2 (SARS-CoV-2) virus. On February 1,"/>
 <result pre="Virus Disease-2019 (COVID- 19)) is presently classified as severe acute" exact="respiratory" post="syndrome CoV 2 (SARS-CoV-2) virus. On February 1, 2020,"/>
 <result pre="Disease-2019 (COVID- 19)) is presently classified as severe acute respiratory" exact="syndrome" post="CoV 2 (SARS-CoV-2) virus. On February 1, 2020, WHO"/>
 <result pre="SARS- CoV- 2 is 3.96 days (4-7 days) which much" exact="lower" post="than 8.4 days documented for SARS CoV.[67] Majority of"/>
 <result pre="lower than 8.4 days documented for SARS CoV.[67] Majority of" exact="infections" post="(approximately 81%) are mildly symptomatic, although these patients can"/>
 <result pre="spread the disease. R0, SI and large number of mildly" exact="symptomatic" post="patients are epidemiologically significant and responsible for the exponential"/>
 <result pre="CoV, MERS CoV is presumed to be bat and the" exact="intermediate" post="hosts of SARS CoV and MERS CoV are palm"/>
 <result pre="human angiotensin converting enzyme 2 (hACE 2) receptor present in" exact="respiratory" post="epithelium and type II pulmonary pneumocyte which is the"/>
 <result pre="enzyme 2 (hACE 2) receptor present in respiratory epithelium and" exact="type II" post="pulmonary pneumocyte which is the same as that of"/>
 <result pre="(hACE 2) receptor present in respiratory epithelium and type II" exact="pulmonary" post="pneumocyte which is the same as that of SARS"/>
 <result pre="entry.[1] The hACE 2 receptors are also expressed in the" exact="heart" post="(cardiac myocytes, endothelium of myocardial vessels), kidney (proximal tubule,"/>
 <result pre="of myocardial vessels), kidney (proximal tubule, distal tubule) and major" exact="blood vessels" post="(endothelium and smooth muscle cells). In the brain, the"/>
 <result pre="tubule, distal tubule) and major blood vessels (endothelium and smooth" exact="muscle" post="cells). In the brain, the above receptors are seen"/>
 <result pre="brain, the above receptors are seen in endothelium and smooth" exact="muscle" post="cells of blood vessels. Animal studies (rat) have shown"/>
 <result pre="receptors are seen in endothelium and smooth muscle cells of" exact="blood vessels." post="Animal studies (rat) have shown that the receptors are"/>
 <result pre="inhibitors/Angiotensin receptor blockers upregulates ACE 2 receptor and increases the" exact="susceptibility to" post="infection lacks evidence. It is advised that patients continue"/>
 <result pre="blockers upregulates ACE 2 receptor and increases the susceptibility to" exact="infection" post="lacks evidence. It is advised that patients continue the"/>
 <result pre="decreases inflammatory response (D) Ivermectin inhibits the interaction between the" exact="viral" post="integrase protein (IN) and the importin (IMP) Î±/Î²1 heterodimer"/>
 <result pre="for IN nuclear import (Not shown as a part of" exact="viral" post="replication cycle). (E) Lopinavir, Ritonavir inhibit the protease enzyme"/>
 <result pre="the protease enzyme SARS- CoV- 2 replicates both in the" exact="upper" post="and lower respiratory tract. This is in contrast with"/>
 <result pre="enzyme SARS- CoV- 2 replicates both in the upper and" exact="lower" post="respiratory tract. This is in contrast with SARS CoV,"/>
 <result pre="SARS- CoV- 2 replicates both in the upper and lower" exact="respiratory" post="tract. This is in contrast with SARS CoV, as"/>
 <result pre="SARS CoV, as the latter has an affinity to the" exact="lower" post="respiratory tract than the upper respiratory tract. The presence"/>
 <result pre="CoV, as the latter has an affinity to the lower" exact="respiratory" post="tract than the upper respiratory tract. The presence and"/>
 <result pre="has an affinity to the lower respiratory tract than the" exact="upper" post="respiratory tract. The presence and multiplication of the virus"/>
 <result pre="an affinity to the lower respiratory tract than the upper" exact="respiratory" post="tract. The presence and multiplication of the virus in"/>
 <result pre="tract. The presence and multiplication of the virus in the" exact="upper" post="respiratory tract is the reason for high infectivity than"/>
 <result pre="The presence and multiplication of the virus in the upper" exact="respiratory" post="tract is the reason for high infectivity than other"/>
 <result pre="of the infected patients are mildly symptomatic, 14% are severely" exact="symptomatic" post="and 5% are critically ill. The most common manifestations"/>
 <result pre="5% are critically ill. The most common manifestations of the" exact="infection" post="include fever (92.8%), cough (69.8%), difficulty in breathing (34.5%),"/>
 <result pre="(7.2%), and diarrhoea (6.1%). The severity and complications of the" exact="disease" post="are significantly higher in the elderly population. Age-dependent changes"/>
 <result pre="of T- and B- lymphocytes lead to excessive production of" exact="type 2" post="cytokines resulting in prolonged inflammatory response and cytokine storm"/>
 <result pre="cytokine storm that might explain the severity in the elderly." exact="Severe" post="manifestations of the respiratory system include pneumonia, ARDS. Other"/>
 <result pre="explain the severity in the elderly. Severe manifestations of the" exact="respiratory" post="system include pneumonia, ARDS. Other manifestations include sepsis, acute"/>
 <result pre="the respiratory system include pneumonia, ARDS. Other manifestations include sepsis," exact="acute" post="kidney injury, arrhythmia, acute cardiac injury, coagulopathy, and shock.[312]"/>
 <result pre="respiratory system include pneumonia, ARDS. Other manifestations include sepsis, acute" exact="kidney injury," post="arrhythmia, acute cardiac injury, coagulopathy, and shock.[312] Neurological manifestations"/>
 <result pre="pneumonia, ARDS. Other manifestations include sepsis, acute kidney injury, arrhythmia," exact="acute" post="cardiac injury, coagulopathy, and shock.[312] Neurological manifestations are more"/>
 <result pre="in those with severe infections.[13] The neurological manifestations may be" exact="secondary" post="to systemic effects of the virus or directly mediated"/>
 <result pre="with severe infections.[13] The neurological manifestations may be secondary to" exact="systemic" post="effects of the virus or directly mediated by the"/>
 <result pre="by the virus. The altered sensorium that occurs in the" exact="infection" post="may due to hypoxia, metabolic derangements or multi-organ dysfunction."/>
 <result pre="the cerebrospinal fluid, are probably mediated through hACE2 receptors. The" exact="viral" post="access to the CNS may be facilitated hematogenously (probably"/>
 <result pre="spread through the cribriform plate.[14] These manifestations include anosmia, dysgeusia," exact="cerebral" post="infarct, Intracerebral hemorrhage, aseptic meningitis, seizures, acute necrotizing encephalopathy."/>
 <result pre="plate.[14] These manifestations include anosmia, dysgeusia, cerebral infarct, Intracerebral hemorrhage," exact="aseptic meningitis," post="seizures, acute necrotizing encephalopathy. seizure and ataxia. It may"/>
 <result pre="include anosmia, dysgeusia, cerebral infarct, Intracerebral hemorrhage, aseptic meningitis, seizures," exact="acute" post="necrotizing encephalopathy. seizure and ataxia. It may also involve"/>
 <result pre="cerebral infarct, Intracerebral hemorrhage, aseptic meningitis, seizures, acute necrotizing encephalopathy." exact="seizure" post="and ataxia. It may also involve the peripheral nervous"/>
 <result pre="necrotizing encephalopathy. seizure and ataxia. It may also involve the" exact="peripheral" post="nervous system causing Guillain Barre syndrome and muscle injury.[131516171819]"/>
 <result pre="may also involve the peripheral nervous system causing Guillain Barre" exact="syndrome" post="and muscle injury.[131516171819] The respiratory failure may also result"/>
 <result pre="involve the peripheral nervous system causing Guillain Barre syndrome and" exact="muscle" post="injury.[131516171819] The respiratory failure may also result from virus-mediated"/>
 <result pre="nervous system causing Guillain Barre syndrome and muscle injury.[131516171819] The" exact="respiratory" post="failure may also result from virus-mediated destruction of medullary"/>
 <result pre="The respiratory failure may also result from virus-mediated destruction of" exact="medullary" post="neurons.[20] These manifestations described are far from complete as"/>
 <result pre="destruction of medullary neurons.[20] These manifestations described are far from" exact="complete" post="as our understanding of the neurotropism and neurovirulence of"/>
 <result pre="manifestations of SARS CoV-2 Laboratory findings of SARS- CoV- 2" exact="infection" post="include normal total blood count with lymphopenia which is"/>
 <result pre="CoV-2 Laboratory findings of SARS- CoV- 2 infection include normal" exact="total" post="blood count with lymphopenia which is the most consistent"/>
 <result pre="SARS- CoV- 2 infection include normal total blood count with" exact="lymphopenia" post="which is the most consistent finding (reduced immunological response"/>
 <result pre="(cardiac injury), elevated levels of D- dimer, prothrombin time and" exact="partial" post="thromboplastin time and thrombocytopenia (consumption coagulopathy), elevated ferritin (severe"/>
 <result pre="of D- dimer, prothrombin time and partial thromboplastin time and" exact="thrombocytopenia" post="(consumption coagulopathy), elevated ferritin (severe inflammation), elevated c- reactive"/>
 <result pre="coagulopathy), elevated ferritin (severe inflammation), elevated c- reactive protein (severe" exact="viral" post="infection) and elevated interleukin-6 (cytokine storm) and procalcitonin (secondary"/>
 <result pre="viral infection) and elevated interleukin-6 (cytokine storm) and procalcitonin (secondary" exact="bacterial" post="infection). Detection of viral nucleic acid from nasopharyngeal swab"/>
 <result pre="interleukin-6 (cytokine storm) and procalcitonin (secondary bacterial infection). Detection of" exact="viral" post="nucleic acid from nasopharyngeal swab by real-time reverse transcriptase-polymerase"/>
 <result pre="are collected from the following sites: nasopharynx, oropharynx, expectorated sputum," exact="lower" post="respiratory tract aspirate, bronchoalveolar lavage and rectal swab. Rapid"/>
 <result pre="collected from the following sites: nasopharynx, oropharynx, expectorated sputum, lower" exact="respiratory" post="tract aspirate, bronchoalveolar lavage and rectal swab. Rapid IgG/IgM"/>
 <result pre="for triage and epidemiological purposes [Figure 4]. Imaging modalities like" exact="chest" post="X-ray shows ill defines opacities in lower zones of"/>
 <result pre="Imaging modalities like chest X-ray shows ill defines opacities in" exact="lower" post="zones of lung with the tendency to involve perihilar"/>
 <result pre="zones of lung with the tendency to involve perihilar and" exact="upper" post="lung fields in severe disease, CT chest reveals bilateral"/>
 <result pre="involve perihilar and upper lung fields in severe disease, CT" exact="chest" post="reveals bilateral ground glass (air space) opacities in peripheral"/>
 <result pre="and upper lung fields in severe disease, CT chest reveals" exact="bilateral" post="ground glass (air space) opacities in peripheral zone with"/>
 <result pre="CT chest reveals bilateral ground glass (air space) opacities in" exact="peripheral" post="zone with predilection to involve lower zones and in"/>
 <result pre="(air space) opacities in peripheral zone with predilection to involve" exact="lower" post="zones and in some patients fine reticular opacities are"/>
 <result pre="effects of cytokine storm), ivermectin (inhibits the interaction between the" exact="viral" post="integrase protein (IN) and the importin (IMP) a/b1 heterodimer"/>
 <result pre="tidal volume and high PEEP setting, renal replacement therapy in" exact="acute" post="kidney injury and other supportive treatment modalities are utilized"/>
 <result pre="volume and high PEEP setting, renal replacement therapy in acute" exact="kidney injury" post="and other supportive treatment modalities are utilized in critically"/>
 <result pre="with severe ARDS is controversial and should be judiciously used.[24252627]" exact="American" post="heart association/American stroke association has proposed guidelines in the"/>
 <result pre="severe ARDS is controversial and should be judiciously used.[24252627] American" exact="heart" post="association/American stroke association has proposed guidelines in the management"/>
 <result pre="is controversial and should be judiciously used.[24252627] American heart association/American" exact="stroke" post="association has proposed guidelines in the management of stroke"/>
 <result pre="association/American stroke association has proposed guidelines in the management of" exact="stroke" post="patients during this pandemic insisting the judicious use of"/>
 <result pre="services during this period, strictly following the suggested protocol.[28] National" exact="multiple sclerosis" post="society also has made recommendations regarding the initiation/continuation/modifications of"/>
 <result pre="sclerosis society also has made recommendations regarding the initiation/continuation/modifications of" exact="disease" post="modifying therapies in multiple sclerosis patients during the pandemic."/>
 <result pre="made recommendations regarding the initiation/continuation/modifications of disease modifying therapies in" exact="multiple sclerosis" post="patients during the pandemic. Immunomodulators that do not increase"/>
 <result pre="the pandemic. Immunomodulators that do not increase the risk of" exact="infection" post="include glatiramer acetate, interferons and natalizumab. Immunomodulators that increase"/>
 <result pre="acetate, interferons and natalizumab. Immunomodulators that increase the risk of" exact="infection" post="include dimethyl fumarate, fingolimod, siponimod and teriflunomide. Immunosuppressants increasing"/>
 <result pre="fumarate, fingolimod, siponimod and teriflunomide. Immunosuppressants increasing the risk of" exact="infection" post="include alemtuzumab, ocrelizumab, rituximab, mitoxantrone and cladribine.[29] With the"/>
 <result pre="the help, many novel methods like affinity purification-mass spectrometry, 29" exact="viral" post="proteins of SARS- CoV- 2 making 332 high confidence"/>
 <result pre="social media, which has resulted in unprecedented awareness of the" exact="disease" post="in a short period of time. The downside has"/>
 <result pre="has resulted in unprecedented awareness of the disease in a" exact="short" post="period of time. The downside has been the confusion"/>
 <result pre="period of time. The downside has been the confusion and" exact="anxiety" post="in the lay public caused by the torrent of"/>
 <result pre="the lay public caused by the torrent of information. The" exact="absence of" post="a specific curative drug and a vaccine has necessitated"/>
 <result pre="contain spread. The high infectivity and the presence of mildly" exact="symptomatic" post="spreaders have resulted in an inability to quickly isolate"/>
 <result pre="number of patients who acutely require intensive care in a" exact="short" post="period of time has overwhelmed the capacity of intensive"/>
 <result pre="and isolation in the earlier local transmission stage of the" exact="disease" post="and surveillance once the epidemic has abated is required"/>
 <result pre="development and strategies to develop mRNA vaccines as well as" exact="viral" post="antigen preparations are in the pipeline. Since the description"/>
 <result pre="pathogenic coronavirusesNat Rev Microbiol2019171819230531947 2RothanHAByrareddySNThe epidemiology and pathogenesis of coronavirus" exact="disease" post="(COVID-19) outbreakJ Autoimmun2020102433doi:10.1016/j.jaut 2020.10243332113704 3LaiCCShihTPKoWCTangHJHsuehPRSevere acute respiratory syndrome coronavirus"/>
 <result pre="and pathogenesis of coronavirus disease (COVID-19) outbreakJ Autoimmun2020102433doi:10.1016/j.jaut 2020.10243332113704 3LaiCCShihTPKoWCTangHJHsuehPRSevere" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019"/>
 <result pre="pathogenesis of coronavirus disease (COVID-19) outbreakJ Autoimmun2020102433doi:10.1016/j.jaut 2020.10243332113704 3LaiCCShihTPKoWCTangHJHsuehPRSevere acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19):The"/>
 <result pre="of coronavirus disease (COVID-19) outbreakJ Autoimmun2020102433doi:10.1016/j.jaut 2020.10243332113704 3LaiCCShihTPKoWCTangHJHsuehPRSevere acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19):The epidemic"/>
 <result pre="5HeymannDLShindoNCOVID-19:What is next for public health?Lancet2020395542532061313 6Report of the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019 (COVID-19)Last cited on 2020"/>
 <result pre="public health?Lancet2020395542532061313 6Report of the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019 (COVID-19)Last cited on 2020 Apr 09Available from: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)"/>
 <result pre="proposed neurotropic mechanismsACS Chem Neurosci202011995832167747 15WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav Immun2020doi:10.1016/j.bbi.2020.03.031 16WangHYLiXLYanZRSunXPHanJZhangBWPotential neurological"/>
 <result pre="associated with SARS-CoV-2 infection:Causality or coincidence?Lancet Neurol2020doi:10.1016/S1474-4422 (20) 30109-5 18PoyiadjiNShahinGNoujaimDStoneMPatelSGriffithBCOVID-19â€&quot;associated" exact="acute" post="hemorrhagic necrotizing encephalopathy:CT and MRI featuresRadiology2020201187doi:10.1148/radiol. 202020118732228363 19LiYCBaiWZHashikawaTThe neuroinvasive"/>
 <result pre="of SARS-CoV2 may be at least partially responsible for the" exact="respiratory" post="failure of COVID-19 patientsJ Med Virol2020doi:10.1002/jmv. 25728 20Neurologic Symptoms"/>
 <result pre="IgG/IgM combined antibody test for SARS-CoV-2medRxiv2020doi:10.1101/2020.03.26.20044883 22HosseinyMKoorakiSGholamrezanezhadAReddySMyersLRadiology perspective of coronavirus" exact="disease" post="2019 (COVID-19):Lessons from severe acute respiratory syndrome and Middle"/>
 <result pre="SARS-CoV-2medRxiv2020doi:10.1101/2020.03.26.20044883 22HosseinyMKoorakiSGholamrezanezhadAReddySMyersLRadiology perspective of coronavirus disease 2019 (COVID-19):Lessons from severe" exact="acute" post="respiratory syndrome and Middle East respiratory syndromeAJR Am J"/>
 <result pre="22HosseinyMKoorakiSGholamrezanezhadAReddySMyersLRadiology perspective of coronavirus disease 2019 (COVID-19):Lessons from severe acute" exact="respiratory" post="syndrome and Middle East respiratory syndromeAJR Am J Roentgenol202015doi:10.2214/AJR.20.22969"/>
 <result pre="perspective of coronavirus disease 2019 (COVID-19):Lessons from severe acute respiratory" exact="syndrome" post="and Middle East respiratory syndromeAJR Am J Roentgenol202015doi:10.2214/AJR.20.22969 23BuonsensoDPianoARaffaelliFBonadiaNDonatiKDFranceschiFnovel"/>
 <result pre="2019 (COVID-19):Lessons from severe acute respiratory syndrome and Middle East" exact="respiratory" post="syndromeAJR Am J Roentgenol202015doi:10.2214/AJR.20.22969 23BuonsensoDPianoARaffaelliFBonadiaNDonatiKDFranceschiFnovel coronavirus disease-19 pnemoniae:A case"/>
 <result pre="COVID-19 with convalescent plasmaJAMA2020doi:10.1001/jama.2020.4783 25GielenVJohnstonSLEdwardsMRAzithromycin induces anti-viral responses in bronchial" exact="epithelial" post="cellsEur Respir J2010366465420150207 26SmithTBushekJProsserTCOVID-19 drug therapyClinical Drug Information, Clinical"/>
 <result pre="2020 Apr 08Available from: https://doi.org/10.1161/STROKEAHA.120.030023 29Guidance for the use of" exact="disease" post="modifying therapies during the COVID-19 pandemicAvailable from: https://www.nationalmssociety.org/What-you-need-to-know-about-Coronavirus-(COVID-19)/DMT-Guidelines-for-Coronavirus-(COVID-19)) 30GordonDEJangGMBouhaddouMXuJObernierKO'mearaMJet"/>
</results>
